Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Clinical trial NCT00479674 · COMPLETED
Trial details
- NCT number
- NCT00479674
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2014-03-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.